According to Sorrento Therapeutics
's latest financial reports the company has -$0.2 B in net assets.
A companyโs net assets is the sum of its assets minus the sum of its liabilities.
Year | Net assets | Change |
---|---|---|
2022-12-31 | $-21.67 M | -127.73% |
2021-12-31 | $78.12 M | -44.48% |
2020-12-31 | $0.14 B | 329.63% |
2019-12-31 | $32.75 M | -84.21% |
2018-12-31 | $0.20 B | 0.43% |
2017-12-31 | $0.20 B | 138.85% |
2016-12-31 | $86.5 M | -38.62% |
2015-12-31 | $0.14 B | 29.64% |
2014-12-31 | $0.10 B | 62.72% |
2013-12-31 | $66.8 M | 978.01% |
2012-12-31 | $6.19 M | 47.23% |
2011-12-31 | $4.2 M | -17.2% |
2010-12-31 | $5.08 M | 58.83% |
2009-12-31 | $3.2 M | -2825.23% |
2008-12-31 | $-0.12 M | -731.64% |
2007-12-31 | $0.01 M | -103.94% |
2006-12-31 | $-0.48 M | 1351.65% |
2005-12-31 | $-0.04 M | -90.46% |
2004-12-31 | $-0.35 M | 0.22% |
2003-12-31 | $-0.34 M |
Company | Net assets | differencediff. | Country |
---|---|---|---|
Karyopharm Therapeutics
KPTI | -$0.14 B | -31.19% | ๐บ๐ธ USA |
Exelixis EXEL | $2.12 B | -1,174.99% | ๐บ๐ธ USA |